Literature DB >> 9810403

Septicaemia in sickle cell anaemia patients: the Ibadan experience.

Y A Aken'ova1, R A Bakare, M A Okunade.   

Abstract

OBJECTIVE: To describe the pattern of septicaemia among sickle cell anaemia patients.
DESIGN: Descriptive study.
SETTING: Haematology Day Care Unit of the University College Hospital, Ibadan, Nigeria.
SUBJECTS: 269 patients with sickle cell anaemia who presented with fever greater than 38 degrees C.
RESULTS: The blood of 97 of the patients exhibited positive growth with isolation of bacteria thereby confirming the diagnosis of septicaemia in them. Fifty seven (59%) of the isolates were gram negative while 40 (41%) were gram positive pathogens. Klebsiella sp. was the predominant gram negative bacteria while Staphylococcus aureus was the predominant gram positive bacteria. The sensitivity tests on the isolates confirmed Ceftozidine (Fortum) was the most effective antibacterial agent for the gram negative and gram positive pathogens. The 172 patients, who had no bacteria pathogens isolated did well with prophylactic broad spectrum antibiotics. Thirty one patients with positive malarial parasites had full anti-malarial therapy.
CONCLUSION: The incidence of gram negative septicaemia is high in patients with sickle cell anaemia. Klebsiella spp. is the predominant gram negative bacterium while Staphylococcus aureus is the predominant gram positive bacterium. Ceftozidine appears to be the most effective antibiotic against both the gram positive and gram negative bacterial infection.

Entities:  

Mesh:

Year:  1998        PMID: 9810403

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  12 in total

1.  Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.

Authors:  Ceri Evans; Katharine Orf; Erzsebet Horvath; Michael Levin; Josu De La Fuente; Subarna Chakravorty; Aubrey J Cunnington
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

Review 2.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

3.  Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.

Authors:  Desiree Seeyave; Ninad Desai; Scott Miller; Sreedhar P Rao; Steve Piecuch
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 4.  Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.

Authors:  Furahini Tluway; Julie Makani
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

5.  Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

Authors:  M E Kizito; E Mworozi; C Ndugwa; G R Serjeant
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

Review 6.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

Review 7.  Sickle Cell Disease in Sub-Saharan Africa.

Authors:  Thomas N Williams
Journal:  Hematol Oncol Clin North Am       Date:  2016-01-28       Impact factor: 3.722

8.  Prevalence and Etiology of Bacteremia in Febrile Children with Sickle Cell Disease at a Nigeria Tertiary Hospital.

Authors:  Biobele Brown; Hannah Dada-Adegbola; Catherine Trippe; Olufunmilayo Olopade
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-06-20       Impact factor: 2.576

9.  Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study.

Authors:  Thomas N Williams; Sophie Uyoga; Alex Macharia; Carolyne Ndila; Charlotte F McAuley; Daniel H Opi; Salim Mwarumba; Julie Makani; Albert Komba; Moses N Ndiritu; Shahnaaz K Sharif; Kevin Marsh; James A Berkley; J Anthony G Scott
Journal:  Lancet       Date:  2009-09-09       Impact factor: 79.321

10.  Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana.

Authors:  Eric S Donkor; Ebenezer Foster-Nyarko; Christabel C Enweronu-Laryea
Journal:  Infect Drug Resist       Date:  2013-07-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.